변비의 치료

키워드

참고문헌 (127)

1. Garrigues V, "Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain", Am J Epidemiol, 159, pp.520~526 (2004)
2. Lembo A, "Chronic constipation", N Engl J Med, 349, pp.1360~1368 (2003)
3. Pare P, "An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking", Am J Gastroenterol, 96, pp.3130~3137 (2001)
4. Jun DW, "A population-based study on bowel habits in a Korean community: prevalence of functional constipation and self-reported constipation", Dig Dis Sci, 51, pp.1471~1477 (2006)
5. Heaton KW, "Defecation frequency and timing, and stool form in the general population: a prospective study", Gut, 33, pp.818~824 (1992)
6. Camilleri M, "Enteric neurodegeneration in ageing", Neurogastroenterol Motil, 20, pp.185~196 (2008)
7. Wald A, "The burden of constipation on quality of life: results of a multinational survey", Aliment Pharmacol Ther, 26, pp.227~236 (2007)
8. Camilleri M, "Behavioural and new pharmacological treatments for constipation: getting the balance right", Gut, 59, pp.1288~1296 (2010)
9. 박무인, "변비 치료에 관한 임상진료지침", 대한소화기학회지, 57(2), pp.100~114 (2011), 대한소화기학회
10. Hull C, "Alleviation of constipation in the elderly by dietary fiber supplementation", J Am Geriatr Soc, 28, pp.410~414 (1980)
11. Sandman PO, "Treatment of constipation with high-bran bread in long-term care of severely demented elderly patients", J Am Geriatr Soc, 31, pp.289~293 (1983)
12. Brown WJ, "Leisure time physical activity in Australian women: relationship with well being and symptoms", Res Q Exerc Sport, 71, pp.206~216 (2000)
13. Sullivan SN, "Does running cause gastrointestinal symptoms? A survey of 93 randomly selected runners compared with controls", N Z Med J, 107, pp.328~333 (1994)
14. Coenen C, "Does physical excercise influence bowel transit time in healthy young men", Am J Gastroenterol, 87, pp.292~295 (1992)
15. Meshkinpour H, "Effect of aerobic exercise on mouth-to-cecum transit time", Gastroenterology, 96, pp.938~941 (1989)
16. Soffer EE, "Effect of exercise on intestinal motility and transit in trained athletes", Am J Physiol, 260, pp.698~G702 (1991)
17. Oteile GJ, "Effect of moderate exercise on bowel habits", Gut, 32, pp.941~944 (1991)
18. Bringham SA, "Effect of exercise and physical fitness on large intestinal function", Gastroenterology, 97, pp.1389~1399 (1989)
19. Keeling WF, "Orocecal transit during mild exercise in women", J Appl Physiol, 68, pp.1350~1353 (1990)
20. Keeling WF, "Gastrointestinal transit during mild exercise", J Appl Physiol, 63, pp.978~981 (1987)
21. Rao SS, "Effects of acute graded exercise on human colonic motility", Am J Physiol, 276, pp.G1221~G1226 (1999)
22. Fenn GC, "A general practice study of the efficacy of Regulan in functional constipation", Br J Clin Pract, 40, pp.192~197 (1986)
23. Ashraf W, "Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation", Aliment Pharmacol Ther, 9, pp.639~647 (1995)
24. Cheskin LJ, "Mechanisms of constipation in older persons and effects of fiber compared with placebo", J Am Geriatr Soc, 43, pp.666~669 (1995)
25. McRorie JW, "Psyllium is superior to docusate sodium for treatment of chronic constipation", Aliment Pharmacol Ther, 12, pp.491~497 (1998)
26. 음준범, "변비 우세형 과민성 장증후군과 만성 변비에서 아기오® 1일 18 g 경구 투여의 효과", Journal of Neurogastroenterology and Motility (JNM), 14(2), pp.115~121 (2008), 대한소화기 기능성질환∙운동학회
27. Kinnunen O, "Constipation in elderly long-stay patients: Its treatment by magnesium hydroxide and bulk laxative", Ann Clin Res, 19, pp.321~323 (1987)
28. 신은경, "대장내시경 전처치로 Polyethylene Glycol 용액과 Magnesium Hydroxide 병합 요법의 효과", 대한소화기학회지, 55(4), pp.232~236 (2010), 대한소화기학회
29. Andorsky RI, "Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study", Am J Gastroenterol, 85, pp.261~265 (1990)
30. Klauser AG, "Polyethylene glycol 4000 for slow transit constipation", Z Gastroenterol, 33, pp.5~8 (1995)
31. Corazziari E, "Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation", Dig Dis Sci, 41, pp.1636~1642 (1996)
32. Freedman MD, "Tolerance and efficacy of polyethylene glycol 3350", electrolyte solution versus lactulose in relieving opiate induced constipation: a doubleblinded placebo-controlled trial, 1997, pp.37, 904~907
33. Attar A, "Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation", Gut, 44, pp.226~230 (1999)
34. Bassotti G, "Use of polyethylene glycol solution in slow transit constipation", Ital J Gastroenterol Hepatol, 31(Supp 3), pp.S255~S256 (1999)
35. Cleveland MV, "New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study", South Med J, 94, pp.478~481 (2001)
36. DiPalma JA, "A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative", Am J Gastroenterol, 95, pp.446~450 (2000)
37. DiPalma JA, "Overnight efficacy of polyethylene glycol laxative", Am J Gastroenterol, 97, pp.1776~1779 (2002)
38. DiPalma JA, "A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation", Am J Gastroenterol, pp.1436~1441 (2007)
39. DiPalma JA, "A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications", South Med J, 100, pp.1085~1090 (2007)
40. 배선환, "Long-term safety of PEG 4000 in children with chronic functional constipation: A biochemical perspective", Korean Journal of Pediatrics, 53(7), pp.741~744 (2010), 대한소아과학회
41. Sanders JF, "Lactulose syrup assessed in a double-blind study of elderly constipated patients", J Am Geriatr Soc, 26, pp.236~239 (1978)
42. Wesselius-De Casparis A, "Treatment of chronic constipation with lactulose syrup: results of a double-blind study", Gut, 9, pp.84~86 (1968)
43. Rouse M, "An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults", Br J Clin Pract, 45, pp.28~30 (1991)
44. 이준성, "만성 기능성 변비 환자에서 락툴로오스 제제가 대장 통과시간 및 증상 개선에 미치는 효과", Journal of Neurogastroenterology and Motility (JNM), 12(2), pp.127~135 (2006), 대한소화기 기능성질환∙운동학회
45. Tack J, "Treatment of chronic constipation: current pharmacologic approaches and future directions", Clin Gastroenterol Hepatol, 7, pp.502~508 (2009)
46. Bosshard W, "The treatment of chronic constipation in elderly people: an update", Drugs Aging, 21, pp.911~930 (2004)
47. Stern FH, "Constipation: an omnipresent symptom: effect of a preparation containing prune concentrate and cascarin", J Am Geriatr Soc, 14, pp.1153~1155 (1966)
48. Kinnunen O, "Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients", Pharmacology, 47(Supp 1), pp.S253~S255 (1993)
49. Connolly P, "Comparison of “uphalac”and “rritant”laxatives during and after treatment of chronic constipation: a preliminary study", Curr Med Res Opin, 2, pp.620~625 (1974)
50. Pers M, "A crossover comparative study with two bulk laxatives", J Int Med Res, 11, pp.51~53 (1983)
51. Williamson J, "A comparative trial of a new laxative", Nurs Times, 71, pp.1705~1707 (1975)
52. Odes HS, "A double-blind trial of celandin, alovera and psyllium laxative preparation in adult patients with constipation", Digestion, 49, pp.65~71 (1991)
53. MacLennan WJ, "A comparison of sodium picosulphate ("Laxoberal") with standardised senna ("Senokot") in geriatric patients", Curr Med Res Opin, 2, pp.641~647 (1975)
54. Passmore AP, "Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination", BMJ, 307, pp.769~771 (1993)
55. Kasdon SC, "The management of puerperal constipation with a senna preparation", J Int Coll Surg, 31, pp.455~458 (1959)
56. Katz R, "Evaluation of standardized senna in the treatment of refractory constipation", Med Press, 243, pp.335~336 (1960)
57. Corman ML, "Management of postoperative constipation in anorectal surgery", Dis Colon Rectum, 22, pp.149~151 (1979)
58. DeLuca VA, "The management of chronic functional constipation in the severely incapacitated, aged nursing home patient", Med Counterpoint, 6, pp.25~27 (1974)
59. Delegge M, "Efficacy of bowel preparation with the use of a prepackaged, low fibre diet with a low sodium, magnesium citrate cathartic vs. a clear liquid diet with a standard sodium phosphate cathartic", Aliment Pharmacol Ther, 21, pp.1491~1495 (2005)
60. Verghese VJ, "Low-salt bowel cleansing preparation (LoSo Prep) as preparation for colonoscopy: a pilot study", Aliment Pharmacol Ther, 16, pp.1327~1331 (2002)
61. Kienzle-Horn S, "Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study", Aliment Pharmacol Ther, 23, pp.1479~1488 (2006)
62. Manabe N, "Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers", Aliment Pharmacol Ther, 30, pp.930~936 (2009)
63. Mueller-Lissner S, "Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation", Am J Gastroenterol, 105, pp.897~903 (2010)
64. Kienzle-Horn S, "Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation", Curr Med Res Opin, 23, pp.691~699 (2007)
65. Hyland CM, "Dioctyl sodium sulphosuccinate as a laxative in the elderly", Practitioner, 200, pp.698~699 (1968)
66. Castle SC, "Constipation prevention: Empiric use of stool softeners questioned", Geriatrics, 46, pp.84~86 (1991)
67. Fain AM, "Treatment of constipation in geriatric and chronically ill patients: a comparison", South Med J, 71, pp.677~680 (1978)
68. Chapman RW, "Effect of oral dioctyl sodium sulfosuccinate on intake-output studies of human small and large intestine", Gastroenterology, 89, pp.489~493 (1985)
69. McRorie JW, "Psyllium is superior to docusate sodium for treatment of chronic constipation", Aliment Pharmacol Ther, 12, pp.491~497 (1998)
70. Kamm MA, "Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study", Am J Gastroenterol, 100, pp.362~372 (2005)
71. Tack J, "A randomized controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation", Gut, 54, pp.1707~1713 (2005)
72. Choi H, "Factors affecting the efficacy of tegaserod in patients with chronic constipation", Intest Res, 5, pp.170~176 (2007)
73. Müller-Lissner S, "Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation", Am J Gastroenterol, 101, pp.2558~2569 (2006)
74. Yong Sung Kim, "The Effect of Tegaserod on Symptoms and Quality of Life in Korean Women with Irritable Bowel Syndrome with Constipation", Journal of Neurogastroenterology and Motility (JNM), 16(1), pp.61~70 (2010), 대한소화기 기능성질환∙운동학회
75. Loughlin J, "Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study", J Cardiovasc Pharmacol Ther, 15, pp.151~157 (2010)
76. Camilleri M, "A placebocontrolled trial of prucalopride for severe chronic constipation", N Engl J Med, 358, pp.2344~2354 (2008)
77. Tack J, "Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives", Gut, 58, pp.357~365 (2009)
78. Quigley EM, "Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation: a 12-week, randomized, double-blind, placebo-controlled study", Aliment Pharmacol Ther, 29, pp.315~328 (2009)
79. Camilleri M, "Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study", Neurogastroenterol Motil, 21, pp.1256~e117 (2009)
80. Camilleri M, "Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonists, ATI-7505, in humans", Neurogastroenterol Motil, 19, pp.30~38 (2007)
81. Manini ML, "Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation", Neurogastroenterol Motil, 22, pp.42~49 (2010)
82. Yang US, "The effect of cisapride tartrate in patients with functional dyspepsia and functional constipation", Korean J Gastrointest Motil, 7, pp.36~46 (2001)
83. Johanson JF, "Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety", Aliment Pharmacol Ther, 25, pp.1351~1361 (2007)
84. Johanson JF, "Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation", Am J Gastroentrol, 103, pp.170~177 (2008)
85. Barish CF, "Efficacy and safety of lubiprostone in patients with chronic constipation", Dig Dis Sci, 55, pp.1090~1097 (2010)
86. Johnston JM, "Pilot study on the effect of linaclotide in patients with chronic constipation", Am J Gastroenterol, 104, pp.125~132 (2009)
87. Lembo AJ, "Efficacy of linaclotide for patients with chronic constipation", Gastroenterology, 138, pp.886~895 (2010)
88. Paulson DM, "Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction: a 21-day treatment-randomized clinical trial", J Pain, 6, pp.184~192 (2005)
89. Webster L, "Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain", Pain, 137, pp.428~440 (2008)
90. Delaney CP, "Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery", Dis Colon Rectum, 48, pp.1114~1125 (2005)
91. Viscusi ER, "Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: result of a randomized, double-blind, controlled study", Surg Endosc, 20, pp.64~70 (2006)
92. Büchler MW, "Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: result of an international randomized, doubleblind, multicentre, placebo-controlled clinical study", Aliment Pharmacol Ther, 28, pp.312~325 (2008)
93. Herzog TJ, "A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy", Am J Obstet Gynecol, 195, pp.445~453 (2006)
94. Thomas J, "Methylnaltrexone for opioid-induced constipation in advanced illness", N Engl J Med, 358, pp.2332~2343 (2008)
95. Portenoy RK, "Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study", J Pain Symptom Manage, 35, pp.458~468 (2008)
96. Slatkin N, "Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients", J Support Oncol, 7, pp.39~46 (2009)
97. Chamberlain BH, "Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness", J Pain Symptom Manage, 38, pp.683~690 (2009)
98. Parkman HP, "Neurotrophin-3 improves functional constipation", Am J Gastroenterol, 98, pp.1338~1347 (2003)
99. Enmmanuel AV, "Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation", Gut, 49, pp.214~219 (2001)
100. Enck P, "Biofeedback training in disordered defecation: a critical review", Dig Dis Sci, 38, pp.1953~1960 (1993)
101. Rao SS, "Effects of biofeedback therapy on anorectal function in obstructive defecation", Dig Dis Sci, 42, pp.2197~2205 (1997)
102. Chiarioni G, "Biofeedback benefits only patients with outlet dysfunction, not patients not patients with isolated slow transit constipation", Gastroenterology, 129, pp.86~97 (2005)
103. Chiotakou-Faliakou E, "Biofeedback provides long term benefit for patients with intractable, slow and normal transit constipation", Gut, 42, pp.517~521 (1998)
104. Mason HJ, "Psychological state and quality of life in patients having behavioral treatment (biofeedback) for intractable constipation", Am J Gastroenterol, 97, pp.3154~3159 (2002)
105. Rao SS, "Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial", Am J Gastroenterol, 105, pp.890~896 (2010)
106. Herve S, "Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow triansit constipation", Neurogastroenterol Motil, 16, pp.397~402 (2004)
107. Jeong JH, "Biofeedback therapy in patients with nonrelaxing puborectalis syndrome: are there differences of therapeutic effect according to methods of diagnosis", J Korean Soc Coloproctol, 17, pp.26~32 (2001)
108. 정기욱, "직장감각저하 환자에서 바이오피드백 치료에 대한 장기간 효과 및 인자 분석", Intestinal research, 6(1), pp.56~59 (2008), 대한장연구학회
109. Chang HS, "Electrical stimulation effect in constipated patients with impaired rectal sensation", Korean J Gastrointest Motil, 8, pp.160~166 (2002)
110. Byoung Hwan Lee, "The Long-term Clinical Efficacy of Biofeedback Therapy for Patients With Constipation or Fecal Incontinence", Journal of Neurogastroenterology and Motility (JNM), 16(2), pp.177~185 (2010), 대한소화기 기능성질환∙운동학회
111. Binnie NR, "Constipation associated with spinal cord injury: the effect of pelvic parasympathetic stimulation by the Brindley stimulator", Paraplegia, 29, pp.463~469 (1991)
112. Pescatori M, "Cologrande C Colonic motility in two constipated neurological patients treated by spinal cord stimulation. In Motility of the digestive tract", pp.541~546 (1982), Raven Press
113. Hervé S, "Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation", Neurogastroenterol Motil, 16, pp.397~402 (2004)
114. Ganio E, "Short-term sacral nerve stimulation for functional anorectal and urinary disturbances: results in 40 patients: evaluation of new option for anorectal functional disorders", Dis Colon Rectum, 44, pp.1261~1267 (2001)
115. Malouf AJ, "Short-term effects of sacral nerve stimulation for idiopathic slow transit constipation", World J Surg, 26, pp.166~170 (2002)
116. Kenefick NJ, "Permanent sacral nerve stimulation for treatment of idiopathic constipation", Br J Surg, 89, pp.882~888 (2002)
117. Kenefick NJ, "Double-blind placebo-controlled crossover study of sacral nerve stimulation for idiopathic constipation", Br J Surg, 89, pp.1570~1571 (2002)
118. Kamm MA, "Sacral nerve stimulation for intractable constipation", Gut, 59, pp.333~340 (2010)
119. Holzer B, "Sacral nerve stimulation in patients with severe constipation", Dis Colon Rectum, 51, pp.524~529 (2008)
120. Vitton V, "Sacral nerve stimulation and constipation: still a long way to go", Dis Colon Rectum, 52, pp.752~753 (2009)
121. Dinning PG, "Sacral nerve stimulation induces pan-colonic propagating pressure waves and increases defecation frequency in patients with slow-transit constipation", Colorectal Dis, 9, pp.123~132 (2007)
122. Song HK, "Noninvasive sacral nerve stimulation for idiopathic slow transit constipation: short term clinical and physiologic effects", Korean J Neurogastroenterol Motil, 9, pp.134~141 (2003)
123. Knowles CH, "Outcome of colectomy for slow transit constipation", Ann Surg, 230, pp.627~638 (1999)
124. Wexner SD, "Colectomy for constipation: physiologic investigation is the key to success", Dis Colon Rectum, 34, pp.851~856 (1991)
125. Lee HC, "Clinical features and functional outcome of the patients with idiopathic chronic constipation who underwent surgical treatment", Korean J Gastrointest Motil, 7, pp.204~215 (2001)
126. Nam KH, "Clinical results of subtotal colectomy in chronic constipation patients", J Korean Soc Coloproctol, 16, pp.395~401 (2000)
127. Lim SW, "Clinical analysis of total colectomy for chronic idiopathic constipation", J Korean Soc Coloproctol, 16, pp.150~155 (2000)

관련 논문AI추천